financetom
Business
financetom
/
Business
/
BRIEF-Safe Bulkers Announces Agreement for Acquisition of One Japanese Kamsarmax Class Dry-bulk Vessel
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Safe Bulkers Announces Agreement for Acquisition of One Japanese Kamsarmax Class Dry-bulk Vessel
Jun 3, 2024 1:27 PM

June 3 (Reuters) - Safe Bulkers Inc:

* SAFE BULKERS, INC. ANNOUNCES AGREEMENT FOR THE

ACQUISITION OF

ONE JAPANESE KAMSARMAX CLASS DRY-BULK VESSEL

* SAFE BULKERS ACQUIRES NEW KAMSARMAX VESSEL

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novonix Obtains Japanese Patent for Battery Technology
Novonix Obtains Japanese Patent for Battery Technology
Jun 27, 2024
03:43 AM EDT, 06/27/2024 (MT Newswires) -- Novonix ( NVX ) said late Wednesday it has been granted a Japanese patent for its cathode synthesis technology. The battery materials company said the technology produces no waste. The company has 10 categories of patent applications under examination in different jurisdictions, it said. Price: 2.1100, Change: +0.05, Percent Change: +2.43 ...
Vigil Neuroscience Receives $40 Million Investment From Sanofi
Vigil Neuroscience Receives $40 Million Investment From Sanofi
Jun 27, 2024
03:40 AM EDT, 06/27/2024 (MT Newswires) -- Vigil Neuroscience ( VIGL ) said Thursday that Sanofi ( SNY ) has made a $40 million strategic investment in the company at an as-converted price of $7.44 per share of common stock. Sanofi ( SNY ) will purchase more than 537,000 of the company's series A non-voting preferred shares, each convertible into...
GSK slides 6% after US CDC narrows scope of RSV shots
GSK slides 6% after US CDC narrows scope of RSV shots
Jun 27, 2024
(Reuters) - GSK's shares dropped more than 6% on Thursday, a day after a U.S. public health agency narrowed its usage recommendation for all respiratory syncytial virus (RSV) vaccines and held off on recommending their use for those under 60 years of age. The U.S. Centers for Disease Control and Prevention (CDC) said late on Wednesday that it now recommended...
SoftBank Group launches AI healthcare joint venture with Tempus AI
SoftBank Group launches AI healthcare joint venture with Tempus AI
Jun 27, 2024
TOKYO, June 27 (Reuters) - Japanese technology investor SoftBank Group ( SFTBF ) has launched a joint venture with Tempus AI ( TEM ) that aims to analyse personal medical data with artificial intelligence (AI) to come up with treatment recommendations. This is the latest in a string of AI investments SoftBank has recently announced as it increases the pace...
Copyright 2023-2026 - www.financetom.com All Rights Reserved